Sign in

CIK 0001520262

  • Large accelerated filer

Alkermes plc.

Sign in to watch
Ticker
ALKS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
981007018
Phone
+353 17728000
Business address
CONNAUGHT HOUSE, 1 BURLINGTON ROAD, DUBLIN 4, Ireland, 00000
Former names
ANTLER SCIENCE TWO PLC, Antler Science Two Ltd
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$697,937
in 4 filings, $698K under 10b5-1 plans

Net −$697,937. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-10-08 Reed Joshua SVP, Chief Financial Officer Exercise or conversion +9,164 9,164
2026-10-08 Reed Joshua SVP, Chief Financial Officer Shares withheld for taxes −4,069 $40.11 $163K 5,095
2026-10-08 Reed Joshua SVP, Chief Financial Officer Exercise or conversion · Restricted Stock Unit Award −9,164 27,492
2026-03-02 Reed Joshua SVP, Chief Financial Officer Grant or award · Employee Stock Option (Right to Buy) +66,430 66,430
2026-03-02 Reed Joshua SVP, Chief Financial Officer Grant or award · Restricted Stock Unit Award +30,854 30,854
2025-10-08 Reed Joshua SVP, Chief Financial Officer Grant or award · Employee Stock Option (Right to Buy) +158,743 158,743
2025-10-08 Reed Joshua SVP, Chief Financial Officer Grant or award · Restricted Stock Unit Award +36,656 36,656

Page 1 of 1 · 7 trades